Skip to main content
. Author manuscript; available in PMC: 2020 Jun 15.
Published in final edited form as: Lancet Glob Health. 2020 Mar;8(3):e440–e450. doi: 10.1016/S2214-109X(20)30003-6

Figure 4.

Figure 4.

Estimated (A) total screening and treatment costs, and (B) average costs per cure, for each intervention scenario over 2018–2030. Costs and outcomes are discounted at a standard rate of 3.5% per year. The percentages above each bar in (A) indicate the proportion of total costs that are due to screening.